Navigation Links
Isis Reports Financial Results and Highlights for First Quarter 2013
Date:5/7/2013

t high-quality partners for our severe neurological disease and cancer programs to augment our own efforts in these two newest areas of our pipeline.  We have been successful implementing this strategy.  Since January of last year, we have initiated five new partnerships that involve neurological diseases and cancer, bringing in more than $125 million in upfront payments and adding partners that are significantly enhancing our drug discovery and development efforts in these therapeutic areas," continued Ms. Parshall.  "We believe that our partnerships are structured to provide the best support and ultimately the best value for each drug.  Our partnership with Roche for our Huntington's disease program is a very good example of how we benefit from the expertise and resources that our partner brings while we maintain control over the discovery and early development of the program.  We look forward to broadly evaluating this program with Roche and developing antisense drugs to treat Huntington's disease."Corporate and Drug Development Highlights

  • Isis and Genzyme were successful in bringing KYNAMRO to the market in the United States for patients with HoFH.  These patients are at high cardiovascular risk and may not be able to reduce their LDL-C sufficiently with currently available lipid-lowering therapies. 
  • Genzyme launched KYNAMRO in the United States for the treatment of patients with HoFH.
  • Isis received a $25 million milestone payment from Genzyme related to the marketing approval of KYNAMRO by the FDA.
  • Genzyme continues to enroll the FOCUS FH study, which is designed to provide 60-week safety and efficacy data in FH patients to support an additional regulatory filing.  Genzyme reached an agreement with the FDA on the design of the FOCUS FH study via a Special Protocol Assessment, or SPA.
  • Isis and its investigators reported positive data from a number of drugs in Isis' pipeline.
    '/>"/>

  • SOURCE Isis Pharmaceuticals, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10

    Related medicine technology :

    1. Perrigo Reports Record Revenue and Adjusted Earnings
    2. Discovery Labs Reports First Quarter 2013 Financial Results
    3. Endo Reports First Quarter Financial Results
    4. Landauer, Inc. Reports Fiscal 2013 Second Quarter Results
    5. Array BioPharma Reports Financial Results for the Third Quarter of Fiscal 2013
    6. Soligenix Reports First Quarter 2013 Financial Results and Highlights Recent Accomplishments
    7. IRIDEX Reports 2013 First Quarter Results
    8. Masimo Reports First Quarter 2013 Financial Results
    9. Neurocrine Biosciences Reports First Quarter 2013 Results
    10. Arena Pharmaceuticals Provides Corporate Update and Reports First Quarter 2013 Financial Results
    11. Mylan Reports a 19% Increase in First Quarter 2013 Adjusted Diluted EPS to $0.62
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/31/2014)... MOUNTAIN VIEW, Calif. , July 31, 2014 ... ) today provided an update on its pipeline ... of 2014, Alexza expects to initiate a Phase ... which is being developed for the management of ... identified two new Staccato -based product candidates ...
    (Date:7/31/2014)... SARASOTA, Fla. , July 31, 2014 ... announced today that it has initiated the development of ... ; and that it has selected Quotient Clinical, ... United Kingdom (UK) to run its early ... a Clinical Trial Application (CTA) by the end of ...
    (Date:7/31/2014)... , July 31, 2014  A substantial share ... decisions about which therapies are included in formularies—say ... according to a new Manhattan Research study, ... The study finds that P&T committee members in ... managers (PBMs) have set a high bar for ...
    Breaking Medicine Technology:Alexza Provides Pipeline Update 2Alexza Provides Pipeline Update 3Alexza Provides Pipeline Update 4Alexza Provides Pipeline Update 5Alexza Provides Pipeline Update 6Rock Creek Pharmaceuticals Provides Update of its European Drug Development Regulatory Strategy and selects Quotient Clinical for its early development programs 2Rock Creek Pharmaceuticals Provides Update of its European Drug Development Regulatory Strategy and selects Quotient Clinical for its early development programs 3Rock Creek Pharmaceuticals Provides Update of its European Drug Development Regulatory Strategy and selects Quotient Clinical for its early development programs 4Formulary Decision Makers Say Pharma-Provided Patient Support Solutions Influence Formulary Placement 2Formulary Decision Makers Say Pharma-Provided Patient Support Solutions Influence Formulary Placement 3
    ... 2011 The MED Group, a Managed Health Care ... www.medicaresuppliersnetwork.com .  The website was created to help answer ... physician offices, about competitive bidding and how patients can ... The Centers for Medicare and Medicaid Services (CMS) ...
    ... 3, 2011 The MED Group, a Managed Health ... www.medicaresuppliersnetwork.com .  The website was created to help ... as physician offices, about competitive bidding and how patients ... The Centers for Medicare and Medicaid Services ...
    Cached Medicine Technology:New Program for Medicare Beneficiaries Will Mean Major Changes Effective January 1, 2011 - Ohio 2New Program for Medicare Beneficiaries Will Mean Major Changes Effective January 1, 2011 - Ohio 3New Program for Medicare Beneficiaries Will Mean Major Changes Effective January 1, 2011 - California 2New Program for Medicare Beneficiaries Will Mean Major Changes Effective January 1, 2011 - California 3
    (Date:7/31/2014)... Andrie, Inc. V. Dept. of Treasury, Mich. S. Ct., ... made the determination that a purchaser of tangible goods in ... unable to prove during an audit that sales tax ... of Appeals decision on whether a purchaser bears the burden ... from Michigan sellers. The Court states “in order to be ...
    (Date:7/31/2014)... Miami, FL (PRWEB) July 31, 2014 ... recently released their innovative compression elbow sleeve , ... other elbow pain, in two new bright colors for ... neon pink and blue. Made of innovative proprietary Zensah® ... moisture wicking and odor-preventing fabric. It features a no-slip ...
    (Date:7/31/2014)... Washington, New York (PRWEB) July 31, 2014 ... represents whistleblowers in qui tam cases, comments that whistleblowers ... an end to illegal employer activities that may cause ... recognizes that today is National Whistleblower Appreciation Day. , ... National Whistleblower Center , the Senate declared "National Whistleblower ...
    (Date:7/31/2014)... NJ (PRWEB) July 31, 2014 ... leading gastroenterologist, Dr. Masood Rizvi, has joined our ... Dr. Rizvi to the community. Hundreds of highly ... Group, a comprehensive network of top doctors and ... of specialties. This latest acquisition represents CarePoint Health’s ...
    (Date:7/31/2014)... (PRWEB) July 31, 2014 You’re having a ... why have you suddenly developed chills and fever, headache, stiff ... you suspect a flu-like illness, it could actually be the ... Your risk of developing Lyme is greater than you might ... new cases occurred in the U.S. annually. But the Centers ...
    Breaking Medicine News(10 mins):Health News:Taxpayer Failing To Prove Sales Tax Was Paid At Time Of Purchase Results In Use Tax Due 2Health News:Taxpayer Failing To Prove Sales Tax Was Paid At Time Of Purchase Results In Use Tax Due 3Health News:Compression Elbow Sleeve Provides Relief From Elbow Pain to Golfers and Tennis Players 2Health News:Compression Elbow Sleeve Provides Relief From Elbow Pain to Golfers and Tennis Players 3Health News:National Whistleblower Appreciation Day Declared to Ensure Recognition of Enormous Contribution to the Democracy by Whistleblowers, Parker Waichman LLP Comments 2Health News:National Whistleblower Appreciation Day Declared to Ensure Recognition of Enormous Contribution to the Democracy by Whistleblowers, Parker Waichman LLP Comments 3Health News:National Whistleblower Appreciation Day Declared to Ensure Recognition of Enormous Contribution to the Democracy by Whistleblowers, Parker Waichman LLP Comments 4Health News:Dr. Rizvi Joins CarePoint Health Medical Group 2Health News:Feel Like You Have A Summertime 'Flu'? It Could Be Lyme Disease 2Health News:Feel Like You Have A Summertime 'Flu'? It Could Be Lyme Disease 3
    ... Governors,University (http://www.wgu.edu ) is now offering its ... managers and nurse educators. These,scholarships are designed to ... become educators, managers, and leaders in various healthcare,settings. ... and,M.S. in Nursing-Leadership and Management degree programs., ...
    ... Oct. 17 Collaborative Drug Discovery,Inc. (CDD, Inc.) ... of,recent publications focused on the fight against Chagas, ... available to researchers free of charge, via,the CDD ... Chemistry, Bioorganic &,Medicinal Chemistry, the Journal of American ...
    ... Looks to Add Even More Space in the ... W.Va., ReBuilder Medical Technologies,Inc. (Pink Sheets: RBRM), ... device inventor David B. Phillips, Ph.D., today,announced it ... demand,of it cutting edge medical devices and products. ...
    ... Pacific Design ... WEST HOLLYWOOD, Calif., Oct. 17 Charles S. Cohen,visionary ... to support AIDS Walk Los Angeles and the City of ... Angeles, in addition to,providing Pacific Design Center as the official ...
    ... consumers manage costs and adopt healthier ... ... in Virginia is now offering new health plan options for employers,and individuals ... healthier lives and gain control over the rising,cost of care. These consumer ...
    ... the Way Toward Malaria ... Eradication U.S. Presidential Candidates Urged to Sustain and Expand President,s ... Malaria Initiative, SEATTLE, Oct. ... - to reach a,day when no human being has malaria, and no mosquito on earth ...
    Cached Medicine News:Health News:Nursing Scholarships Offered by Western Governors University for Master's Degree Programs 2Health News:Free Access to Literature Data on Chagas' Disease Offered Online: Collaborative Drug Discovery, Inc. provides Neglected Disease researchers with 'archive mine and collaborate' access to small molecule bioactivity SAR data on parasitic disease 2Health News:ReBuilder Medical Technologies, Inc. Increases Manufacturing Space to Meet Demand 2Health News:ReBuilder Medical Technologies, Inc. Increases Manufacturing Space to Meet Demand 3Health News:Charles S. Cohen, Pacific Design Center Augment Their Support for AIDS Walk Los Angeles 2Health News:Charles S. Cohen, Pacific Design Center Augment Their Support for AIDS Walk Los Angeles 3Health News:Anthem Blue Cross and Blue Shield in Virginia Introduces New Generation of Consumer Driven Health Products 2Health News:Anthem Blue Cross and Blue Shield in Virginia Introduces New Generation of Consumer Driven Health Products 3Health News:Anthem Blue Cross and Blue Shield in Virginia Introduces New Generation of Consumer Driven Health Products 4Health News:Bill and Melinda Gates Call for New Global Commitment to Chart a Course for Malaria Eradication 2Health News:Bill and Melinda Gates Call for New Global Commitment to Chart a Course for Malaria Eradication 3
    ... AEM Laparoscopic Instruments incorporate a layered design ... shielded and monitored to prevent stray electrosurgical ... caused by insulation failure or capacitive coupling; ... shield built into all AEM Instruments provides ...
    S-VHS Hi-Fi Video Cassette Recorder...
    DP 2020 Series 3-chip cameras offer the user unparalleled clarity and definition. Chroma dynamic range is extended and red colour reproduction is superb....
    ... protection in three formats, ... with lightweight comfort and ... Lenses provide .75 mm ... anti-reflection coated and tempered ...
    Medicine Products: